K Aston-Mourney, J Proietto, G Morahan, S … - Diabetologia, 2008 - Springer Abstract In many countries, first- or second-line pharma- cological treatment of
patients with type 2 diabetes consists of sulfonylureas (such as glibenclamide
[known as glyburide in the USA and Canada]), which stimulate the beta cell ... Cited by 11 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org JM Sosenko, JP Krischer, JP Palmer, J Mahon … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—A risk score based on a model including log-BMI, age, log-fasting
C-peptide, and postchallenge glucose and C-peptide sums from 2-h oral glucose
tolerance tests (OGTTs) was derived from the development sample. The ... Cited by 6 - Related articles - BL Direct - All 5 versions
- ►nursing2008.com TTL Pang, P Narendran - Diabetic Medicine, 2008 - pt.wkhealth.com Type 1 diabetes is recognised to include an element of insulin resistance.
Insulin resistance is an independent risk factor for the development of macro-
and microvascular complications of Type 1 diabetes and may also contribute ... Cited by 4 - Related articles - All 5 versions
MI Hawa, C Thivolet, D Mauricio, I Alemanno, E … - Diabetes Care, 2009 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A consecutive series of patients attending
hospital-based diabetes clinics were assessed for the frequency of metabolic
syndrome and compared with population-based control subjects as part of the ... Cited by 3 - Related articles - All 3 versions
S Fourlanos, LC Harrison, PG Colman - Current Opinion in Endocrinology, Diabetes and …, 2008 - journals.lww.com Recent findings: Insulin resistance is an independent risk factor for
progression to clinical type 1 diabetes in people with islet autoimmunity.
Higher bodyweight is also associated with type 1 diabetes development ... Cited by 2 - Related articles - All 2 versions
TJ Wilkin - International Journal of Obesity, 2009 - nature.com International Journal of Obesity is a monthly, multi-disciplinary forum for papers
describing basic, clinical and applied studies in biochemistry, genetics and ... Cited by 2 - Related articles - All 3 versions
JL Mahon, JM Sosenko, L Rafkin-Mervis, H … - Pediatric Diabetes, 2009 - ingentaconnect.com Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson
C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS,
for the TrialNet Natural History Committee and Type 1 Diabetes TrialNet ... Cited by 1 - Related articles - All 2 versions
X Ma, D Becker, VC Arena, P Vicini, C … - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc Context: Understanding the role of insulin resistance in type 1 diabetes may
lead to new prevention strategies. Estimates of insulin resistance in
first-degree relatives of those with type 1 diabetes may be obtained using ... Related articles - All 4 versions
D Cuthbertson, JM Lachin, JS Skyler - Diabetes Care, 2008 - Am Diabetes Assoc OBJECTIVE — The accurate prediction of type 1 diabetes is essential for
appropriately iden- tifying prevention trial participants. Thus, we have
developed a risk score for the prediction of type 1 diabetes. Related articles
